Innate Pharma S.A.

IPHA Health Care Biotechnology: Biological Products (No Diagnostic Substances)

$1.76

▲ +2.0% Today

as of Jul 22, 09:05 ET

Last 30 days +0.28% Jun 12 → Jul 21

Open

$1.79

High

$1.83

Low

$1.71

Volume

$5,553

Avg Vol

$73,898

Mkt Cap

$163M

P/E (TTM)

—

Beta

—

52w High

$2.63

52w Low

$1.17

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 2 items

Jul 21 · 08:10 MT Newswires

Innate Pharma Closes Enrollment in Phase 1 Advanced Solid Tumors Study

Jul 21 · 05:00 PR Business Wire

Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)

Overview

52-week range

$1.17

$2.63

41% of range

Avg surprise (last 0)

—

Avg reaction (last 0)

—

Earnings trends

Implied volatility — last 90 days

No IV snapshots yet for IPHA.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

LLY

Eli Lilly and Company

Merck & Company, Inc.

$307.2B $126.74+0.4%

Philip Morris International Inc

View on Nasdaq ↗